Parallel Advisors, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,422
+129.2%
555
+423.6%
0.00%
Q2 2023$4,984
+18.8%
106
+6.0%
0.00%
Q1 2023$4,196
+10.0%
1000.0%0.00%
Q4 2022$3,814
-4.6%
100
-6.5%
0.00%
Q3 2022$4,000
-20.0%
107
-27.7%
0.00%
Q2 2022$5,000
-28.6%
148
-15.9%
0.00%
Q4 2021$7,000
-22.2%
176
-17.8%
0.00%
Q3 2021$9,000
+50.0%
214
+94.5%
0.00%
Q2 2021$6,000
-25.0%
1100.0%0.00%
Q1 2021$8,000
-20.0%
1100.0%0.00%
-100.0%
Q4 2020$10,000
+42.9%
1100.0%0.00%
Q3 2020$7,000110
+450.0%
0.00%
Q2 2020$0
-100.0%
20
-88.3%
0.00%
Q1 2020$4,0000.0%171
+533.3%
0.00%
Q3 2019$4,000
-20.0%
270.0%0.00%
Q2 2019$5,000
+25.0%
270.0%0.00%
Q1 2019$4,000
+300.0%
27
+200.0%
0.00%
Q3 2018$1,000
-50.0%
9
-47.1%
0.00%
Q2 2018$2,000
-33.3%
17
-19.0%
0.00%
Q1 2018$3,000210.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders